@article{8cda8bfa86ad484dbf9a5b10fae19116,
title = "Assessment and reporting of quality-of-life measures in pivotal clinical trials of hematological malignancies",
keywords = "Hematologic Neoplasms/epidemiology, Humans, Quality of Life",
author = "Hadidi, {Samer Al} and Kamble, {Rammurti T.} and George Carrum and Heslop, {Helen E.} and Ramos, {Carlos Almeida}",
note = "Funding Information: S.A.H. reports salary support by the National Institutes of Health National Heart, Lung, and Blood Institute (grant 5T32HL092332-18). H.E.H. receives research support from the National Institutes of Health National Cancer Institute (grants P50CA126752 and P01CA094237), Stand Up To Cancer (SU2C)/American Association for Cancer Research (AACR) (grant 604817), Meg Vosburg T-Cell Lymphoma Dream Team, Funding Information: S.A.H. reports salary support by the National Institutes of Health National Heart, Lung, and Blood Institute (grant 5T32HL092332-18). H.E.H. receives research support from the National Institutes of Health National Cancer Institute (grants P50CA126752 and P01CA094237), Stand Up To Cancer (SU2C)/American Association for Cancer Research (AACR) (grant 604817), Meg Vosburg T-Cell Lymphoma Dream Team, and the Leukemia and Lymphoma Society. SU2C is a program of the Entertainment Industry Foundation administered by the AACR.",
year = "2021",
month = nov,
day = "23",
doi = "10.1182/bloodadvances.2021004190",
language = "English (US)",
volume = "5",
pages = "4630--4633",
journal = "Blood Advances",
issn = "2473-9529",
publisher = "American Society of Hematology",
number = "22",
}